Renal and cardiovascular events: do they deserve the same consideration in clinical trials?

被引：3
|
作者：
Ruilope, Luis M. [1 ]
Segura, Julian [1 ]
Fujita, Toshiro [2 ]
Ritz, Eberhard [3 ]
机构：
[1] Hosp 12 Octubre, Hypertens Unit, Dept Nephrol, E-28041 Madrid, Spain
[2] Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Tokyo, Japan
[3] Ruperto Carola Univ Heidelberg, Div Nephrol, Dept Internal Med, Heidelberg, Germany
来源：
JOURNAL OF HYPERTENSION | 2009年 / 27卷 / 09期
关键词：
RANDOMIZED CONTROLLED-TRIAL; KIDNEY-DISEASE; BLOOD-PRESSURE; OUTCOMES; RISK; PERINDOPRIL; NEPHROPATHY; MULTICENTER; RATIONALE; RAMIPRIL;
D O I：
10.1097/HJH.0b013e32832e0b19
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：1743 / 1745
页数：3
相关论文
共 50 条
  • [11] Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence?
    Mallat, Samir G.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [12] Efficacy and Safety of a Polypill to Reduce Cardiovascular Events: A Review of Clinical Trials
    Kelly, Michael S.
    Dacey, Ana
    Siana, Audrey
    Ojeda, Jason
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 83 (01) : 8 - 15
  • [13] Cardiovascular risk assessment in oncological clinical trials: is there a role for centralized events adjudication?
    Vaduganathan, Muthiah
    Prasad, Vinay
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (02) : 128 - 132
  • [14] Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events
    Jackson, Graham
    Kloner, Robert A.
    Costigan, Timothy M.
    Warner, Margaret R.
    Emmick, Jeffrey T.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2004, 1 (02): : 161 - 167
  • [15] Cardiovascular Events in Patients Receiving Alogliptin: A Pooled Analysis of Randomized Clinical Trials
    White, William B.
    Gorelick, Philip B.
    Fleck, Penny
    Smith, Neila
    Wilson, Craig
    Pratley, Richard
    [J]. DIABETES, 2010, 59 : A105 - A105
  • [16] Statistical Consideration of Vaccine Clinical Trials
    Nam, Jusun
    Kang, Seung-Ho
    [J]. KOREAN JOURNAL OF APPLIED STATISTICS, 2011, 24 (04) : 633 - 646
  • [17] CARDIOVASCULAR EVENTS DO NOT ACCELERATE DECLINE OF RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Jeyaruban, A.
    Hoy, W. E.
    Cameron, A.
    Healy, H. G.
    Zhang, J.
    Mallett, A. J.
    [J]. NEPHROLOGY, 2018, 23 : 44 - 44
  • [18] Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials
    Lamanna, C.
    Monami, M.
    Marchionni, N.
    Mannucci, E.
    [J]. DIABETES OBESITY & METABOLISM, 2011, 13 (03): : 221 - 228
  • [19] Gastrointestinal and cardiovascular adverse events of NSAIDS in children clinical trials (RCTs): a systematic review
    Balzarin, M.
    Pariente, A.
    Salvo, F.
    Giaquinto, C.
    Sturkenboom, M.
    Fourrier-Reglat, A.
    Zulian, F.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 423 - 423
  • [20] Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies
    Bonsu, Janice M.
    Guha, Avirup
    Charles, Lawrence
    Yildiz, Vedat O.
    Wei, Lai
    Baker, Brandee
    Brammer, Jonathan E.
    Awan, Farrukh
    Lustberg, Maryam
    Reinbolt, Raquel
    Miller, Eric D.
    Jneid, Hani
    Ruz, Patrick
    Carter, Rebecca R.
    Milks, Michael W.
    Paskett, Electra D.
    Addison, Daniel
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (06) : 620 - 628
12345